within Pharmacolibrary.Drugs.ATC.C;

model C09AA14
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.2,
    Cl             = 0.0025,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Temocapril is an angiotensin-converting enzyme (ACE) inhibitor used primarily for the treatment of hypertension and congestive heart failure. It lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. Although widely used in some Asian and European countries, temocapril is not currently approved in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for a typical healthy adult population after oral administration. Published data on detailed compartmental PK modeling is lacking, so parameters are reported as best estimates from summarized clinical pharmacokinetic studies.</p><h4>References</h4><ol><li><p>Püchler, K, et al., &amp; Roots, I (1997). Pharmacokinetics of temocapril and temocaprilat after 14 once daily oral doses of temocapril in hypertensive patients with varying degrees of renal impairment. <i>British journal of clinical pharmacology</i> 44(6) 531–536. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2125.1997.t01-1-00622.x&quot;>10.1046/j.1365-2125.1997.t01-1-00622.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9431827/&quot;>https://pubmed.ncbi.nlm.nih.gov/9431827</a></p></li><li><p>Oguchi, H, et al., &amp; Furuta, S (1993). Pharmacokinetics of temocapril and enalapril in patients with various degrees of renal insufficiency. <i>Clinical pharmacokinetics</i> 24(5) 421–427. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199324050-00006&quot;>10.2165/00003088-199324050-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8504625/&quot;>https://pubmed.ncbi.nlm.nih.gov/8504625</a></p></li><li><p>Sierakowski, B, et al., &amp; Roots, I (1997). Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment. <i>European journal of clinical pharmacology</i> 53(3-4) 215–220. DOI:<a href=&quot;https://doi.org/10.1007/s002280050365&quot;>10.1007/s002280050365</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9476034/&quot;>https://pubmed.ncbi.nlm.nih.gov/9476034</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C09AA14;
